Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK
- PMID: 34607828
- PMCID: PMC8491294
- DOI: 10.1136/bmjdrc-2021-002146
Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK
Abstract
Introduction: We aimed to determine the incidence of, and risk factors for all-cause/cardiovascular disease (CVD) mortality, and end-stage renal disease (ESRD) among people with type 2 diabetes with/without diabetic kidney disease (DKD) in the UK general population.
Research design and methods: We undertook a population-based cohort study using primary care UK electronic health records. We followed 8413 people with type 2 diabetes and DKD and a matched comparison cohort of people with type 2 diabetes without DKD. Risk factors for all-cause/CVD mortality (using both cohorts) and ESRD (DKD cohort only) were evaluated by estimating HRs with 95% CIs using Cox regression.
Results: In the DKD cohort (mean age 66.7 years, 62.4% male), incidence rates per 1000 person-years were 50.3 (all-cause mortality), 8.0 (CVD mortality) and 6.9 (ESRD). HRs (95% CIs; DKD vs comparison cohort) were 1.49 (1.35 to 1.64) for all-cause mortality and 1.60 (1.24 to 2.05) for CVD mortality. In general, higher all-cause mortality risks were seen with older age, underweight (body mass index <20 kg/m2), reduced renal function, and cardiovascular/liver disease, and lower risks were seen with being female or overweight. In the DKD cohort, higher risks of ESRD were seen with reduced renal function at baseline, high material deprivation, cancer and non-insulin glucose-lowering drugs, and a lower risk was seen with overweight (≥25 kg/m2).
Conclusions: Annually, one death will occur among every 20 people with type 2 diabetes and DKD. The identified risk factors in this study will help identify people with type 2 diabetes at most risk of death and progression of kidney disease, and help to direct effective management strategies.
Keywords: chronic; epidemiology; kidney failure; mortality; risk factors.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: DV is a full-time employee of Bayer Hispania, Barcelona, Spain. LGR, AG-P and MS work for CEIFE (Madrid, Spain), which has received research funding from Bayer. LGR has also received honoraria for serving on advisory boards for Bayer. ML has received research grants from AstraZeneca, DexCom and Novo Nordisk and been consultant for AstraZeneca, DexCom, Eli Lilly, MSD and Novo Nordisk.
Similar articles
-
Impact of chronic kidney disease definition on assessment of its incidence and risk factors in patients with newly diagnosed type 1 and type 2 diabetes in the UK: A cohort study using primary care data from the United Kingdom.Prim Care Diabetes. 2020 Aug;14(4):381-387. doi: 10.1016/j.pcd.2019.11.002. Epub 2019 Nov 30. Prim Care Diabetes. 2020. PMID: 31791904
-
Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.BMC Med. 2021 Mar 15;19(1):66. doi: 10.1186/s12916-021-01936-3. BMC Med. 2021. PMID: 33715620 Free PMC article.
-
Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.Ren Fail. 2022 Dec;44(1):562-570. doi: 10.1080/0886022X.2022.2056053. Ren Fail. 2022. PMID: 35373711 Free PMC article.
-
Changing trends in end-stage renal disease due to diabetes in the United kingdom.J Ren Care. 2012 Feb;38 Suppl 1:12-22. doi: 10.1111/j.1755-6686.2012.00273.x. J Ren Care. 2012. PMID: 22348360 Review.
-
Diabetic kidney disease: a report from an ADA Consensus Conference.Am J Kidney Dis. 2014 Oct;64(4):510-33. doi: 10.1053/j.ajkd.2014.08.001. Am J Kidney Dis. 2014. PMID: 25257325
Cited by
-
Association between diabetic status and risk of all-cause and cause-specific mortality on dialysis following first kidney allograft loss.Clin Kidney J. 2024 Mar 7;17(3):sfad245. doi: 10.1093/ckj/sfad245. eCollection 2024 Mar. Clin Kidney J. 2024. PMID: 38468698 Free PMC article.
-
Sexually dimorphic response to tobacco in the development of chronic kidney disease: a systematic review.BMC Nephrol. 2024 Nov 26;25(1):424. doi: 10.1186/s12882-024-03845-y. BMC Nephrol. 2024. PMID: 39587497 Free PMC article.
-
Predictive models and determinants of mortality among T2DM patients in a tertiary hospital in Ghana, how do machine learning techniques perform?BMC Endocr Disord. 2025 Jan 10;25(1):9. doi: 10.1186/s12902-025-01831-5. BMC Endocr Disord. 2025. PMID: 39794757 Free PMC article.
-
Prevalence and Risk Factors of Abnormal Glucose Metabolism and New-Onset Diabetes Mellitus after Kidney Transplantation: A Single-Center Retrospective Observational Cohort Study.Medicina (Kaunas). 2022 Nov 7;58(11):1608. doi: 10.3390/medicina58111608. Medicina (Kaunas). 2022. PMID: 36363565 Free PMC article.
-
Trends in mortality and comorbidities in hemodialysis patients between 2012 and 2017 in an East-European Country: a retrospective study.Int Urol Nephrol. 2023 Oct;55(10):2579-2587. doi: 10.1007/s11255-023-03549-6. Epub 2023 Mar 14. Int Urol Nephrol. 2023. PMID: 36917413 Free PMC article.
References
-
- Saeedi P, Petersohn I, Salpea P, et al. . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019;157:107843. 10.1016/j.diabres.2019.107843 - DOI - PubMed
-
- Yee J. Diabetic kidney disease: chronic kidney disease and diabetes. Diabetes Spectrum 2008;21:8–10. 10.2337/diaspect.21.1.8 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical